| Literature DB >> 30413483 |
Sang-Kyu Lee1,2, Woo-Jeong Jeong1,2, Yong-Hee Cho1,2, Pu-Hyeon Cha1,2, Jeong-Su Yoon1,2, Eun Ji Ro1,2, Sooho Choi1,3, Jeong-Min Oh1,3, Yunseok Heo1,3, Hyuntae Kim1,2, Do Sik Min1,4, Gyoonhee Han1,2, Weontae Lee1,3, Kang-Yell Choi5,2.
Abstract
RAS proteins play critical roles in various cellular processes, including growth and transformation. RAS proteins are subjected to protein stability regulation via the Wnt/β-catenin pathway, and glycogen synthase kinase 3 beta (GSK3β) is a key player for the phosphorylation-dependent RAS degradation through proteasomes. GSK3β-mediated RAS degradation does not occur in cells that express a nondegradable mutant (MT) β-catenin. Here, we show that β-catenin directly interacts with RAS at the α-interface region that contains the GSK3β phosphorylation sites, threonine 144 and threonine 148 residues. Exposure of these sites by prior β-catenin degradation is required for RAS degradation. The introduction of a peptide that blocks the β-catenin-RAS interaction by binding to β-catenin rescues the GSK3β-mediated RAS degradation in colorectal cancer (CRC) cells that express MT β-catenin. The coregulation of β-catenin and RAS stabilities by the modulation of their interaction provides a mechanism for Wnt/β-catenin and RAS-ERK pathway cross-talk and the synergistic transformation of CRC by both APC and KRAS mutations.Entities:
Keywords: GSK3β phosphorylation of RAS; colorectal cancer; regulation of RAS stability; α‐Interface region of RAS; β‐Catenin‐RAS interaction
Mesh:
Substances:
Year: 2018 PMID: 30413483 PMCID: PMC6280641 DOI: 10.15252/embr.201846060
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 8.807